The NYT reports on efforts to limit the corruption of medical research by preventing articles ghost authored by drug companies from appearing in medical research. It would have been worth noting that this problem would not exist in the absence of the enormous rents that drug companies earn from patent monopolies. These rents give the drug companies incentives to mislead the public about the effectiveness of their drugs.
--Dean Baker
If you enjoyed this article, please consider making a tax-deductible donation today. For over 30 years, The American Prospect has delivered independent reporting that exposes corporate power, investigates political corruption, and analyzes threats to our democracy. Unlike many media outlets, we’re not owned by billionaires or corporations—we’re powered by readers like you.
Today’s independent journalism faces unprecedented challenges. Your support makes our reporting possible and keeps our work free and accessible to all. Whether it’s $5 or $50, every contribution helps sustain our nonprofit newsroom.
Join our community of supporters and make a donation today to help keep independent journalism thriving.
